HALEON PLC (HLNCF) Financials
HLNCF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 34.1 billion | 17.3 billion |
| Sept. 30, 2023 | ? | ? |
| June 30, 2023 | 34.2 billion | 17.6 billion |
| March 31, 2023 | ? | ? |
HLNCF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | ? | ? |
| Sept. 30, 2023 | ? | ? |
| June 30, 2023 | ? | ? |
| March 31, 2023 | ? | ? |
HLNCF Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2023 | -3.0 million |
| Sept. 30, 2023 | 365.0 million |
| June 30, 2023 | 298.0 million |
| March 31, 2023 | 389.0 million |
HLNCF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 1.0 billion | - | - |
| Sept. 30, 2023 | - | - | - |
| June 30, 2023 | 490.0 million | - | 146.0 million |
| March 31, 2023 | - | - | - |
HLNCF Shares Outstanding
HLNCF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | 94.0 million | 1.1 billion | - |
| Sept. 30, 2023 | - | 75.0 million | 1.1 billion | - |
| June 30, 2023 | - | 67.0 million | 1.1 billion | - |
| March 31, 2023 | - | 75.0 million | 1.1 billion | - |
HLNCF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | 2.8 billion | 1.3 billion |
| Sept. 30, 2023 | 2.8 billion | 1.1 billion |
| June 30, 2023 | 2.8 billion | 1.0 billion |
| March 31, 2023 | 3.0 billion | 1.1 billion |
HLNCF
Price: $4.12
Dividend Yield: 1.84%
Forward Dividend Yield: 2.58%
Payout Ratio: 75.86%
Dividend Per Share: 0.11 USD
Earnings Per Share: 0.14 USD
P/E Ratio: 29.38
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 37.6 billion
Average Dividend Frequency: 2
Years Paying Dividends: 2